Filing Details

Accession Number:
0001808805-22-000093
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-16 20:19:19
Reporting Period:
2022-08-12
Accepted Time:
2022-08-16 20:19:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808805 Nautilus Biotechnology Inc. NAUT Laboratory Analytical Instruments (3826) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1865778 B. Matthew Murphy C/O Nautilus Biotechnology, Inc.
2701 Eastlake Avenue East
Seattle WA 98102
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-12 2,500 $2.85 46,640 No 4 P Indirect See Footnote
Common Stock Acquisiton 2022-08-15 7,500 $2.84 54,140 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,250 Direct
Footnotes
  1. Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.
  2. 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.